PMC:7200337 / 32631-32905 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T332","span":{"begin":22,"end":26},"obj":"Body_part"},{"id":"T333","span":{"begin":36,"end":47},"obj":"Body_part"},{"id":"T334","span":{"begin":262,"end":273},"obj":"Body_part"}],"attributes":[{"id":"A332","pred":"fma_id","subj":"T332","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A333","pred":"fma_id","subj":"T333","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A334","pred":"fma_id","subj":"T334","obj":"http://purl.org/sig/ont/fma/fma62863"}],"text":"l. observed extensive cell death of lymphocytes and suggested potential roles for IL-6 as well as Fas-FasL interactions (Chen et al., 2020h). In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T377","span":{"begin":22,"end":26},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"l. observed extensive cell death of lymphocytes and suggested potential roles for IL-6 as well as Fas-FasL interactions (Chen et al., 2020h). In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T149","span":{"begin":82,"end":84},"obj":"Chemical"},{"id":"T151","span":{"begin":177,"end":179},"obj":"Chemical"},{"id":"T153","span":{"begin":191,"end":201},"obj":"Chemical"},{"id":"T154","span":{"begin":202,"end":213},"obj":"Chemical"}],"attributes":[{"id":"A149","pred":"chebi_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A150","pred":"chebi_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A151","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A152","pred":"chebi_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A153","pred":"chebi_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A154","pred":"chebi_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":"l. observed extensive cell death of lymphocytes and suggested potential roles for IL-6 as well as Fas-FasL interactions (Chen et al., 2020h). In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes "}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T129","span":{"begin":22,"end":32},"obj":"http://purl.obolibrary.org/obo/GO_0008219"}],"text":"l. observed extensive cell death of lymphocytes and suggested potential roles for IL-6 as well as Fas-FasL interactions (Chen et al., 2020h). In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes "}

{"project":"LitCovid-PubTator","denotations":[{"id":"1065","span":{"begin":82,"end":86},"obj":"Gene"},{"id":"1066","span":{"begin":102,"end":106},"obj":"Gene"},{"id":"1071","span":{"begin":224,"end":226},"obj":"Gene"},{"id":"1083","span":{"begin":202,"end":213},"obj":"Chemical"},{"id":"1086","span":{"begin":27,"end":32},"obj":"Disease"}],"attributes":[{"id":"A1065","pred":"tao:has_database_id","subj":"1065","obj":"Gene:3569"},{"id":"A1066","pred":"tao:has_database_id","subj":"1066","obj":"Gene:356"},{"id":"A1071","pred":"tao:has_database_id","subj":"1071","obj":"Gene:6999"},{"id":"A1083","pred":"tao:has_database_id","subj":"1083","obj":"MESH:C502936"},{"id":"A1086","pred":"tao:has_database_id","subj":"1086","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"l. observed extensive cell death of lymphocytes and suggested potential roles for IL-6 as well as Fas-FasL interactions (Chen et al., 2020h). In support of this hypothesis, the IL-6 receptor antagonist tocilizumab was found to increase the number of circulating lymphocytes "}